Opus Genetics
IRD
27 hedge funds and large institutions have $3.19M invested in Opus Genetics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
23% more capital invested
Capital invested by funds: $2.58M → $3.19M (+$605K)
0% more funds holding
Funds holding: 27 → 27 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$21.9K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$18.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.11K |
| 4 |
BlackRock
New York
|
+$6.33K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$51.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 3 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
-$21K |
| 4 |
Jane Street
New York
|
-$19K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$618 |
IRD Hedge Fund Activity: Q3 2018 in Review
27 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2018, worth a combined $3.19M — up 23% from $2.58M a quarter earlier.
Fund positioning in IRD was balanced in Q3 2018: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $21.9K. The largest seller was Virtu Financial, cutting an estimated $51.3K.
- 27 institutional investors held Opus Genetics (IRD) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $3.19M of Opus Genetics stock for Q3 2018, up 23% quarter-over-quarter.
- 4 funds opened new Opus Genetics positions in Q3 2018 and 4 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q3 2018 was Two Sigma Securities, an estimated $21.9K added.
- The largest Opus Genetics seller in Q3 2018 was Virtu Financial, an estimated $51.3K sold.
Based on aggregated 13F filings for Q3 2018.